David Rosenberg
  • Inicio
  • Sobre mí
  • Publicaciones
  • Servicios
  • Contacto
  • Ingalfarma
  • Truenode

Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study

  • web_admin
  • junio 2, 2022
    • Publicaciones
Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4 T Cell Proliferation _ In vit

PREVIOUS STORY

Association between the use of statins and periodontal status: a review

NEXT STORY

Cambios del estado clínico periodontal según consumo sistémico de estatinas
  • Publicaciones Recientes

    • The influence of splinting procedures on the periodontal and peri-implant tissue damping characteristics
    • Short-term Effects of 2% Atorvastatin Dentifrice as an Adjunct to Periodontal Therapy: A Randomized Double Blind Clinical Trial
    • Interaction between Different Implant Surfaces and Liquid Fibrinogen: A Pilot In Vitro Experiment
    • Implant stability related to insertion torque force and bone density: An in vitro study
    • Efficacy on supragingival plaque control of cetylpyridinium chloride in a slow-release dosage form
  • Archivos

    • junio 2022
  • Categorías

    • Publicaciones